Relationship between Carotid Atherosclerosis and Plasma Endothelin-1 Concentration in Senile Patients with Hypertension

The relationship between carotid atherosclerosis and plasma endothelin-1 (ET-1) concentration was studied in senile patients with essential hypertension. A total of 212 patients (83M, 129F; mean age, 63 years) with essential hypertension (WHO stage I-II), and 109 age-matched control subjects (mean a...

Full description

Saved in:
Bibliographic Details
Published inNihon Rōnen Igakkai zasshi Vol. 34; no. 12; pp. 1009 - 1016
Main Authors Yamamoto, Yuta, Yamano, Shigeru, Minami, Shigetoshi, Nomura, Kumiko, Nakatani, Akira, Sawai, Nobuyuki, Fukui, Rie, Takaoka, Minoru, Dohi, Kazuhiro
Format Journal Article
LanguageJapanese
Published Japan The Japan Geriatrics Society 1997
Subjects
Online AccessGet full text
ISSN0300-9173
DOI10.3143/geriatrics.34.1009

Cover

Abstract The relationship between carotid atherosclerosis and plasma endothelin-1 (ET-1) concentration was studied in senile patients with essential hypertension. A total of 212 patients (83M, 129F; mean age, 63 years) with essential hypertension (WHO stage I-II), and 109 age-matched control subjects (mean age, 61 years) were enrolled in the study. The maximum thicknesses of the intima-media complex (IMTmax) in the right common carotid artery (CCA) and the right internal carotid artery (ICA) was measured by B-mode ultrasonography, and ET-1 was measured by enzyme immunoassay. ET-1 levels were significantly higher in the hypertensive patients than in the control subjects. In middle-aged patients (35-64 years old), IMTmax values of the ICA in patients with high ET-1 concentrations (ET-≥1.71pg/ml) were significantly higher than in patients with normal ET-1 concentrations (ET-1<1.71pg/ml). However, the IMTmax of the CCA did not show a similar correlation. In senile patients (65-83 years old), both the CCA and ICA IMTmax values were significantly higher in patients with high ET-1 concentrations than in those with normal ET-1 concentrations. These results indicate that high ET-1 levels in middle-aged patients with essential hypertension may play a role in the progression of ICA atherosclerosis. High ET-1 levels in senile patients with essential hypertension may cause progression of atherosclerosis in both the ICA and CCA.
AbstractList The relationship between carotid atherosclerosis and plasma endothelin-1 (ET-1) concentration was studied in senile patients with essential hypertension. A total of 212 patients (83M, 129F; mean age, 63 years) with essential hypertension (WHO stage I-II), and 109 age-matched control subjects (mean age, 61 years) were enrolled in the study. The maximum thicknesses of the intima-media complex (IMTmax) in the right common carotid artery (CCA) and the right internal carotid artery (ICA) was measured by B-mode ultrasonography, and ET-1 was measured by enzyme immunoassay. ET-1 levels were significantly higher in the hypertensive patients than in the control subjects. In middle-aged patients (35-64 years old), IMTmax values of the ICA in patients with high ET-1 concentrations (ET-≥1.71pg/ml) were significantly higher than in patients with normal ET-1 concentrations (ET-1<1.71pg/ml). However, the IMTmax of the CCA did not show a similar correlation. In senile patients (65-83 years old), both the CCA and ICA IMTmax values were significantly higher in patients with high ET-1 concentrations than in those with normal ET-1 concentrations. These results indicate that high ET-1 levels in middle-aged patients with essential hypertension may play a role in the progression of ICA atherosclerosis. High ET-1 levels in senile patients with essential hypertension may cause progression of atherosclerosis in both the ICA and CCA.
The relationship between carotid atherosclerosis and plasma endothelin-1 (ET-1) concentration was studied in senile patients with essential hypertension. A total of 212 patients (83 M, 129 F; mean age, 63 years) with essential hypertension (WHO stage I-II), and 109 age-matched control subjects (mean age, 61 years) were enrolled in the study. The maximum thicknesses of the intima-media complex (IMTmax) in the right common carotid artery (CCA) and the right internal carotid artery (ICA) was measured by B-mode ultrasonography, and ET-1 was measured by enzyme immunoassay. ET-1 levels were significantly higher in the hypertensive patients than in the control subjects. In middle-aged patients (35-64 years old), IMTmax values of the ICA in patients with high ET-1 concentrations (ET-1 > or = 1.71 pg/ml) were significantly higher than in patients with normal ET-1 concentrations (ET-1 < 1.71 pg/ml). However, the IMTmax of the CCA did not show a similar correlation. In senile patients (65-83 years old), both the CCA and ICA IMTmax values were significantly higher in patients with high ET-1 concentrations than in those with normal ET-1 concentrations. These results indicate that high ET-1 levels in middle-aged patients with essential hypertension may play a role in the progression of ICA atherosclerosis. High ET-1 levels in senile patients with essential hypertension may cause progression of atherosclerosis in both the ICA and CCA.The relationship between carotid atherosclerosis and plasma endothelin-1 (ET-1) concentration was studied in senile patients with essential hypertension. A total of 212 patients (83 M, 129 F; mean age, 63 years) with essential hypertension (WHO stage I-II), and 109 age-matched control subjects (mean age, 61 years) were enrolled in the study. The maximum thicknesses of the intima-media complex (IMTmax) in the right common carotid artery (CCA) and the right internal carotid artery (ICA) was measured by B-mode ultrasonography, and ET-1 was measured by enzyme immunoassay. ET-1 levels were significantly higher in the hypertensive patients than in the control subjects. In middle-aged patients (35-64 years old), IMTmax values of the ICA in patients with high ET-1 concentrations (ET-1 > or = 1.71 pg/ml) were significantly higher than in patients with normal ET-1 concentrations (ET-1 < 1.71 pg/ml). However, the IMTmax of the CCA did not show a similar correlation. In senile patients (65-83 years old), both the CCA and ICA IMTmax values were significantly higher in patients with high ET-1 concentrations than in those with normal ET-1 concentrations. These results indicate that high ET-1 levels in middle-aged patients with essential hypertension may play a role in the progression of ICA atherosclerosis. High ET-1 levels in senile patients with essential hypertension may cause progression of atherosclerosis in both the ICA and CCA.
The relationship between carotid atherosclerosis and plasma endothelin-1 (ET-1) concentration was studied in senile patients with essential hypertension. A total of 212 patients (83 M, 129 F; mean age, 63 years) with essential hypertension (WHO stage I-II), and 109 age-matched control subjects (mean age, 61 years) were enrolled in the study. The maximum thicknesses of the intima-media complex (IMTmax) in the right common carotid artery (CCA) and the right internal carotid artery (ICA) was measured by B-mode ultrasonography, and ET-1 was measured by enzyme immunoassay. ET-1 levels were significantly higher in the hypertensive patients than in the control subjects. In middle-aged patients (35-64 years old), IMTmax values of the ICA in patients with high ET-1 concentrations (ET-1 > or = 1.71 pg/ml) were significantly higher than in patients with normal ET-1 concentrations (ET-1 < 1.71 pg/ml). However, the IMTmax of the CCA did not show a similar correlation. In senile patients (65-83 years old), both the CCA and ICA IMTmax values were significantly higher in patients with high ET-1 concentrations than in those with normal ET-1 concentrations. These results indicate that high ET-1 levels in middle-aged patients with essential hypertension may play a role in the progression of ICA atherosclerosis. High ET-1 levels in senile patients with essential hypertension may cause progression of atherosclerosis in both the ICA and CCA.
Author Yamano, Shigeru
Sawai, Nobuyuki
Fukui, Rie
Minami, Shigetoshi
Takaoka, Minoru
Nakatani, Akira
Dohi, Kazuhiro
Yamamoto, Yuta
Nomura, Kumiko
Author_xml – sequence: 1
  fullname: Yamamoto, Yuta
  organization: First Department of Internal Medicine, Nara Medical University
– sequence: 1
  fullname: Yamano, Shigeru
  organization: First Department of Internal Medicine, Nara Medical University
– sequence: 1
  fullname: Minami, Shigetoshi
  organization: First Department of Internal Medicine, Nara Medical University
– sequence: 1
  fullname: Nomura, Kumiko
  organization: First Department of Internal Medicine, Nara Medical University
– sequence: 1
  fullname: Nakatani, Akira
  organization: First Department of Internal Medicine, Nara Medical University
– sequence: 1
  fullname: Sawai, Nobuyuki
  organization: First Department of Internal Medicine, Nara Medical University
– sequence: 1
  fullname: Fukui, Rie
  organization: First Department of Internal Medicine, Nara Medical University
– sequence: 1
  fullname: Takaoka, Minoru
  organization: First Department of Internal Medicine, Nara Medical University
– sequence: 1
  fullname: Dohi, Kazuhiro
  organization: First Department of Internal Medicine, Nara Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/9493468$$D View this record in MEDLINE/PubMed
BookMark eNpNkUtLQzEQhbNQfP8BQcjK3a2Tm9xHllJ8gaL4WIc0d2Ijt7k1SSn996a2VDczMOd8szjnmOz5wSMh5wxGnAl-9YnB6RSciSMuRgxA7pEj4ACFZA0_JGcxuglUrZCiruGAHEghuajbI7J8xV4nN_g4dXM6wbRE9HSsw5BcR6_TFMMQTb-eLlLtO_rS6zjT9MZ3Q1Z75wtGx4M36FP4_USdp2_oXY_0JR_yPdKlS1N6v5pjSOhjNp2Sfav7iGfbfUI-bm_ex_fF4_Pdw_j6sTClZKloNTRYlUJOjIUKGmEsQisrJurOaGt1WTNbt42xre0AhIQOmDCigdLwstL8hFxu_s7D8L3AmNTMRYN9rz0Oi6gaWdWNlCwbL7bGxWSGnZoHN9NhpbZJZb3c6CZHEQPanYOBWpeg_kpQXKh1CRl62kBfMelP3CE6JJdD_YcwWYtfrNzONb_zmakOCj3_Ae9EnJM
ContentType Journal Article
Copyright The Japan Geriatrics Society
Copyright_xml – notice: The Japan Geriatrics Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.3143/geriatrics.34.1009
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EndPage 1016
ExternalDocumentID 9493468
10_3143_geriatrics_34_1009
article_geriatrics1964_34_12_34_12_1009_article_char_en
Genre English Abstract
Journal Article
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
CS3
F5P
JSF
KQ8
OK1
RJT
123
2WC
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c291t-8a07e5249bcf05074cfe0895146dcaffa261f687cf8fd00490d014c4702c325a3
ISSN 0300-9173
IngestDate Thu Jul 10 22:53:41 EDT 2025
Wed Feb 19 02:32:49 EST 2025
Tue Jul 01 00:43:53 EDT 2025
Wed Sep 03 06:23:42 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 12
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c291t-8a07e5249bcf05074cfe0895146dcaffa261f687cf8fd00490d014c4702c325a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/geriatrics1964/34/12/34_12_1009/_article/-char/en
PMID 9493468
PQID 79567991
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_79567991
pubmed_primary_9493468
crossref_primary_10_3143_geriatrics_34_1009
jstage_primary_article_geriatrics1964_34_12_34_12_1009_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 1900
PublicationDate 1997-00-00
PublicationDateYYYYMMDD 1997-01-01
PublicationDate_xml – year: 1997
  text: 1997-00-00
PublicationDecade 1990
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Nihon Rōnen Igakkai zasshi
PublicationTitleAlternate Nippon Ronen Igakkai Zasshi
PublicationYear 1997
Publisher The Japan Geriatrics Society
Publisher_xml – name: The Japan Geriatrics Society
References 40) Sharefkin JB, Diamond SL, Eskin SG, McIntire LV, Dieffenbach CW: Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells. J Vasc Surg 1991; 14: 1-9.
30) Gariepy J, Massonneau M, Levenson J, Heudes D, Simon A: Evidence for in vivo carotid and femoral wall thickening in human hypertension. Hypertension 1993; 22: 111-118.
20) WHO/ISH Guidelines Sub-Committee: 1993 guidelines for the management of mild hypertension: Memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993; 11: 905-918.
14) Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R: Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406.
32) 小松本悟, 奈良昌治: 血漿 Endothelin-1 値における加齢の影響について. 日老医誌1995; 32: 664-669.
1) Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
25) Friedman MH, Hutchins GM, Bargeron CB, Deters OJ, Mark FF: Correlation between intimal thickness and fluid shear in human arteries. Atherosclerosis 1981; 39: 425-436.
26) 植田初江, 由谷親夫, 今村正美: 頸動脈硬化症の初期病変に関する病理学的検討. 動脈硬化1988; 16: 565-571.
23) Solberg LA, Eggen DA: Locarization and sequence of development of atherosclerotic lesions in the carotid and vertebral arteries. Circulation 1971; 43: 711-724.
19) Bonithon-Kopp C, Scarabin P-Y, Taquet A, Touboul P-J, Malmejac A, Guize L: Risk factors for early carotid atherosclerosis in middle-aged French women. Arterosclerosis and Thrombosis 1991; 11: 966-972.
3) Garg UC, Hassaid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-1777.
6) Hirata Y, Takagi Y, Fukuda Y, Marumo F: Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989; 78: 225-228.
8) Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD, et al: Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990; 172: 1741-1748.
33) Saito Y, Nakao K, Mukoyama M, Shirakami G, Itoh H, Yamada T, et al: Application of monoclonal antibodies for endothelin to hypertensive reserch. Hypertension 1990; 15: 734-738.
10) Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S, Fukunaga R, et al: Ultrasonic evaluation of early carotid atherosclerosis. Stroke 1990; 21: 1567-1572.
13) Bogousslavsky J, Regli F: Borderzone infarctions distal to internal carotid artery occulusion: Prognostic implications. Ann Neurol 1986; 20: 346-350.
18) Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R: Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. Atherosclerosis 1988; 70: 253-261.
29) Haudenschild CC, Prescott MF, Chobanian AV: Effects of hypertension and its reversal on aortic intima lesions of the rat. Hypertension 1980; 2: 33-44.
22) 松原純一, 山田育男, 太田敬, 塩野谷恵彦, 佐々木隆一郎, 青木国雄, 新城健蔵: 日本人における頭蓋外の頸動脈病変頻度. 脈管学 1985; 25: 295-298.
15) Salonen JT, Salonen R: Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arteriosclerosis and Thrombosis 1991; 11: 1245-1249.
21) Suzuki N, Matsumoto H, Kitada C, Masaki T, Fujino M: A sensitive sandwich-enzyme immunoassay for human endothelin. J Immunol Method 1989; 118: 245-250.
5) Hamberg M, Svensson J, Samuelsson B: Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Nat Acad Sci USA 1975; 72: 2994-2998.
9) Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JG: Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325: 997-1001.
7) Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S: Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 1990; 258: C408-C415.
16) Salonen R, Salonen JT: Progression of carotid atherosclerosis and its determinants: A population-based ultrasonography study. Atherosclerosis 1990; 81: 33-40.
34) Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C, et al: A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: Comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 1990; 78: 261-264.
35) Yokokawa K, Tahara H, Kohno M, Murakawa K, Yasunari K, Nakagawa K, et al: Hypertension associated with endothelin-secreting malignant hemangioendothelioma. Ann Intern Med 1991; 114: 213-215.
38) Schiffrin EL, Thibault G: Plasma endothelin in human essential hypertension. Am J Hypertens 1991; 4: 303-308.
28) Owens GK, Schwartz SM: Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res 1983; 53: 491-501.
39) Douglas SA, Louden C, Vickery-Clark LM, Storer BL, Hart T, Feuerstein GZ, et al: A role for endogenous endothelin-1 in neointimal formation after rat carotid artery baloon angioplasty. Circ Res 1994; 75: 190-197.
31) Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, et al: Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990; 15: 493-496.
36) Nishikibe M, Tsuchida S, Okabe M, Fukuroda T, Shimamoto K, Yano M, et al: Antihypertensive effect of newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sci 1993; 52: 717-724.
17) Crouse JR, Harpold GH, Kahl FR, Toole JF, Mckinney WM: Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B-mode ultrasound. Stroke 1986; 17: 270-275.
37) Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, et al: Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990; 88: 614-618.
2) Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
12) 井門浩美, 長束一行, 佐藤洋, 浅岡伸光, 佐野道孝, 増田喜一ほか: 頸動脈病変と危険因子および脳梗塞との関連性. 脈管学1995; 35: 411-417.
27) 丸山路之: 超音波断層法による総頸動脈近位部中内膜肥厚度計測の意義. 脈管学1995; 35: 77-82.
11) Heyman A, Wilkinson WE, Heyden S, Helms MJ, Bartel AG, Karp HR, et al: Risk of stroke in asymptomatic persons with cervical arterial bruits: A population study in Evans county, Georgia. N Engl J Med 1980; 302: 838-841.
4) Folkow B, Johansson B, Mellander S: The comparative effects of angiotensin and noradrenaline on consecutive vascular sections. Acta Physiol Scand 1961; 53: 99-104.
41) Malek AM, Greene AL, Lzumo S: Regulation of endothelin 1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. Proc Natl Acad Sci USA 1993; 90: 5999-6003.
24) Sakata N, Joshita T, Ooneda G: Topographical study on arterosclerotic lesions at the bifurcations of human cerebral arteries. Heart and Vessels 1985; 1: 70-73.
References_xml – reference: 12) 井門浩美, 長束一行, 佐藤洋, 浅岡伸光, 佐野道孝, 増田喜一ほか: 頸動脈病変と危険因子および脳梗塞との関連性. 脈管学1995; 35: 411-417.
– reference: 27) 丸山路之: 超音波断層法による総頸動脈近位部中内膜肥厚度計測の意義. 脈管学1995; 35: 77-82.
– reference: 22) 松原純一, 山田育男, 太田敬, 塩野谷恵彦, 佐々木隆一郎, 青木国雄, 新城健蔵: 日本人における頭蓋外の頸動脈病変頻度. 脈管学 1985; 25: 295-298.
– reference: 23) Solberg LA, Eggen DA: Locarization and sequence of development of atherosclerotic lesions in the carotid and vertebral arteries. Circulation 1971; 43: 711-724.
– reference: 37) Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, et al: Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990; 88: 614-618.
– reference: 6) Hirata Y, Takagi Y, Fukuda Y, Marumo F: Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989; 78: 225-228.
– reference: 35) Yokokawa K, Tahara H, Kohno M, Murakawa K, Yasunari K, Nakagawa K, et al: Hypertension associated with endothelin-secreting malignant hemangioendothelioma. Ann Intern Med 1991; 114: 213-215.
– reference: 5) Hamberg M, Svensson J, Samuelsson B: Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Nat Acad Sci USA 1975; 72: 2994-2998.
– reference: 38) Schiffrin EL, Thibault G: Plasma endothelin in human essential hypertension. Am J Hypertens 1991; 4: 303-308.
– reference: 11) Heyman A, Wilkinson WE, Heyden S, Helms MJ, Bartel AG, Karp HR, et al: Risk of stroke in asymptomatic persons with cervical arterial bruits: A population study in Evans county, Georgia. N Engl J Med 1980; 302: 838-841.
– reference: 30) Gariepy J, Massonneau M, Levenson J, Heudes D, Simon A: Evidence for in vivo carotid and femoral wall thickening in human hypertension. Hypertension 1993; 22: 111-118.
– reference: 14) Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R: Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406.
– reference: 26) 植田初江, 由谷親夫, 今村正美: 頸動脈硬化症の初期病変に関する病理学的検討. 動脈硬化1988; 16: 565-571.
– reference: 25) Friedman MH, Hutchins GM, Bargeron CB, Deters OJ, Mark FF: Correlation between intimal thickness and fluid shear in human arteries. Atherosclerosis 1981; 39: 425-436.
– reference: 15) Salonen JT, Salonen R: Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arteriosclerosis and Thrombosis 1991; 11: 1245-1249.
– reference: 10) Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S, Fukunaga R, et al: Ultrasonic evaluation of early carotid atherosclerosis. Stroke 1990; 21: 1567-1572.
– reference: 41) Malek AM, Greene AL, Lzumo S: Regulation of endothelin 1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. Proc Natl Acad Sci USA 1993; 90: 5999-6003.
– reference: 1) Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
– reference: 18) Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R: Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. Atherosclerosis 1988; 70: 253-261.
– reference: 7) Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S: Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 1990; 258: C408-C415.
– reference: 17) Crouse JR, Harpold GH, Kahl FR, Toole JF, Mckinney WM: Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B-mode ultrasound. Stroke 1986; 17: 270-275.
– reference: 3) Garg UC, Hassaid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83: 1774-1777.
– reference: 16) Salonen R, Salonen JT: Progression of carotid atherosclerosis and its determinants: A population-based ultrasonography study. Atherosclerosis 1990; 81: 33-40.
– reference: 13) Bogousslavsky J, Regli F: Borderzone infarctions distal to internal carotid artery occulusion: Prognostic implications. Ann Neurol 1986; 20: 346-350.
– reference: 34) Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C, et al: A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: Comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 1990; 78: 261-264.
– reference: 24) Sakata N, Joshita T, Ooneda G: Topographical study on arterosclerotic lesions at the bifurcations of human cerebral arteries. Heart and Vessels 1985; 1: 70-73.
– reference: 31) Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, et al: Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990; 15: 493-496.
– reference: 39) Douglas SA, Louden C, Vickery-Clark LM, Storer BL, Hart T, Feuerstein GZ, et al: A role for endogenous endothelin-1 in neointimal formation after rat carotid artery baloon angioplasty. Circ Res 1994; 75: 190-197.
– reference: 20) WHO/ISH Guidelines Sub-Committee: 1993 guidelines for the management of mild hypertension: Memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993; 11: 905-918.
– reference: 8) Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD, et al: Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990; 172: 1741-1748.
– reference: 29) Haudenschild CC, Prescott MF, Chobanian AV: Effects of hypertension and its reversal on aortic intima lesions of the rat. Hypertension 1980; 2: 33-44.
– reference: 36) Nishikibe M, Tsuchida S, Okabe M, Fukuroda T, Shimamoto K, Yano M, et al: Antihypertensive effect of newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive model. Life Sci 1993; 52: 717-724.
– reference: 21) Suzuki N, Matsumoto H, Kitada C, Masaki T, Fujino M: A sensitive sandwich-enzyme immunoassay for human endothelin. J Immunol Method 1989; 118: 245-250.
– reference: 4) Folkow B, Johansson B, Mellander S: The comparative effects of angiotensin and noradrenaline on consecutive vascular sections. Acta Physiol Scand 1961; 53: 99-104.
– reference: 40) Sharefkin JB, Diamond SL, Eskin SG, McIntire LV, Dieffenbach CW: Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells. J Vasc Surg 1991; 14: 1-9.
– reference: 19) Bonithon-Kopp C, Scarabin P-Y, Taquet A, Touboul P-J, Malmejac A, Guize L: Risk factors for early carotid atherosclerosis in middle-aged French women. Arterosclerosis and Thrombosis 1991; 11: 966-972.
– reference: 28) Owens GK, Schwartz SM: Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res 1983; 53: 491-501.
– reference: 32) 小松本悟, 奈良昌治: 血漿 Endothelin-1 値における加齢の影響について. 日老医誌1995; 32: 664-669.
– reference: 33) Saito Y, Nakao K, Mukoyama M, Shirakami G, Itoh H, Yamada T, et al: Application of monoclonal antibodies for endothelin to hypertensive reserch. Hypertension 1990; 15: 734-738.
– reference: 9) Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JG: Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325: 997-1001.
– reference: 2) Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
SSID ssib058494660
ssj0055462
ssib002821993
ssib005879752
ssib000994798
ssib000940319
Score 1.4655721
Snippet The relationship between carotid atherosclerosis and plasma endothelin-1 (ET-1) concentration was studied in senile patients with essential hypertension. A...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 1009
SubjectTerms Adult
Aged
Aged, 80 and over
Arteriosclerosis - blood
Arteriosclerosis - pathology
Carotid Artery Diseases - blood
Carotid Artery Diseases - pathology
Carotid atherosclerosis
Elderly
Endothelin-1
Endothelin-1 - blood
Essential hypertension
Female
Humans
Hypertension - blood
Hypertension - pathology
Male
Middle Aged
Ultrasonography
Title Relationship between Carotid Atherosclerosis and Plasma Endothelin-1 Concentration in Senile Patients with Hypertension
URI https://www.jstage.jst.go.jp/article/geriatrics1964/34/12/34_12_1009/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/9493468
https://www.proquest.com/docview/79567991
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 1997/12/25, Vol.34(12), pp.1009-1016
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECXctCh6KboFcVcempMhVwslisfASOC2iNElAdKTQG22YlgqbAlB8zv90c6IlMykCdDUB8KWSEnWPIzeUG-GhLzPOXyk41oMYmSLSd-xZBDGlpcKRzohECUXk5OPZ8H0lH06888Gg9-Gaqmp43FyeWNeyf9YFbaBXTFL9g6W7Q8KG-A72BdasDC0_2TjXslmKq5QwlEX6egAqV21gSHQFqoU8xfgyis5OixTTLwChmk5mPOnFJqd7PF7VoKrwOL9xTb9bQrx6rpVu2s7akI7KxYw6lu1P5nsh6yE83-cy-VSFqNLoOWLojdogSvft3Oti2Ke1ZWx74dcyXYFcLVv3fTTPvJCrZY9q-LmV7PsR8yqVbNWyWzNqlhW27kLVLQYzs2zbXC0ahmTzhPraU2NONfwq45tC-MZjVMON_l_D9gfGG2OJsYFDjZjj423Y81i29cegr00EYIiPEq0PUbkMazsLO6R-y7nDupGP381OKxgmAlm_BaMGzEsxLQoktw6vZAL7vecEggglvi3O_qAqkH96kvdIJXphdf04e__dYVNPTiHgGKe3R4rtZzp5Al5rIMdeqCQ-5QMzuUz8vBYyzmekwsTwFQDmGoA02sApgBgqgBMTQDTKwCmRUkVgGkHYIoApiaAX5DTo8OTydTSK4FYiSuc2gqlzTPfZSJOchsiGJbkmR1CcMCCNJF5Lt3AyYOQJ3mYp-3L7BRC_4Rx200815feLtkpqzLbI9SXPGM8DEQcpsx2UuH6mR0LL-EJc_IsH5JRd0ejn6rgS3Q7JobkSN30vq92BkZfLHnX9nd1iwP7fphcCb5sSN51RovAweNbO1lmVbOJuPADDlHckOwqW_anEkx4LAhf3umKX5FHqgIzziK-Jjv1usneAK-u47ctrv8AJgrPYg
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relationship+between+Carotid+Atherosclerosis+and+Plasma+Endothelin-1+Concentration+in+Senile+Patients+with+Hypertension&rft.jtitle=Nihon+Ro%CC%84nen+Igakkai+zasshi&rft.au=Minami%2C+Shigetoshi&rft.au=Yamano%2C+Shigeru&rft.au=Sawai%2C+Nobuyuki&rft.au=Nomura%2C+Kumiko&rft.date=1997&rft.issn=0300-9173&rft.volume=34&rft.issue=12&rft.spage=1009&rft.epage=1016&rft_id=info:doi/10.3143%2Fgeriatrics.34.1009&rft.externalDBID=n%2Fa&rft.externalDocID=10_3143_geriatrics_34_1009
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-9173&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-9173&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-9173&client=summon